Navigation Links
Cholesterol-Stroke Relationship Puzzles Researchers
Date:11/30/2007

ularly for people with a systolic blood pressure (the top number in a reading) above 145 mm/Hg -- a finding that left Lewington puzzled.

"Maybe we're not measuring the right thing," she said. "Maybe it's more complicated than that."

An accompanying editorial by two stroke experts at Denis Diderot University in Paris offered one statistical explanation. It suggests that the combination of high cholesterol and elevated blood pressure might have killed off the most vulnerable part of the study population before their eighth decade -- leaving a hardier group of people behind.

Lewington said she wasn't prepared to join in on those speculations.

One expert said he isn't surprised by the findings, since stroke is a more complicated condition than heart attack.

Dr. Deepak Bhatt is associate director of the Cleveland Clinic's cardiovascular coordinating center. He noted that while heart attack has a single cause -- buildup of fatty deposits that block a coronary artery -- a stroke can be caused by a blockage in a carotid artery (a main blood vessel to the brain), a clot in an artery within the brain, a rupture of an artery, or an irregular heartbeat called atrial fibrillation that sends a clot to the brain.

There's also another scenario, in which someone survives a stroke but is so weakened that he or she quickly succumbs to heart disease, Bhatt said. In such cases, stroke is not even mentioned as the cause of the death, he said.

All this "can create something of a messy picture that can lead some people to conclude that control of cholesterol is not important for stroke prevention," he said. However, "from the patient's perspective, nothing here contradicts the fact that if they have high cholesterol, they should get it treated. It would be bad if the public gets a mixed message," Bhatt stressed.

More information

There's more on preventing stroke at the

Copyright©2007 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Acupuncturists Relocation Tightens Relationship With Fertility Clinic
2. Draxis Health selected by Johnson and Johnson Consumer Companies, Inc. for major contract manufacturing relationship
3. New study examines brain-gut relationship in those suffering with stomach pain or discomfort
4. Coalition America Renews Relationship with Musketeer to Offer Streamlined Claims Repricing and Adjudication Solution for Benefit Administrators
5. Alter-G Forging New Relationships
6. MD On-Line Expands Relationship with Aetna for Direct Claim Submission
7. Contract Renewal Extends Thomson Healthcares Long-Standing Relationship with University Hospitals
8. Covance Agrees to Enter Strategic Relationship with eResearchTechnology to Offer its Clients eRTs Centralized Cardiac Safety Services
9. Stanford researchers find culprit in aging muscles that heal poorly
10. UCLA researchers identify markers that may predict diabetes in still-healthy people
11. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cholesterol-Stroke Relationship Puzzles Researchers
Cholesterol-Stroke Relationship Puzzles Researchers
Breaking Medicine Technology:Boston Scientific Announces Pricing of $2 Billion of Senior Notes 2Boston Scientific Announces Pricing of $2 Billion of Senior Notes 3Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 2Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 3Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 4Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 5Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 6AdEx Media, Inc. Signs Agreement with Medical Alarm Concepts 2AdEx Media, Inc. Signs Agreement with Medical Alarm Concepts 3Delayed First Visit to Dentist Can Affect Childrens Lifelong Oral Health 58581 1Delayed First Visit to Dentist Can Affect Childrens Lifelong Oral Health 58581 2Sleep Center at Baylor Dallas One of Select Centers in North Texas to Receive Accreditation 58576 1Sleep Center at Baylor Dallas One of Select Centers in North Texas to Receive Accreditation 58576 2United States Patent Office Allows Claims Covering the Approved Administration of Kuvan with Food 5114 1United States Patent Office Allows Claims Covering the Approved Administration of Kuvan with Food 5114 2United States Patent Office Allows Claims Covering the Approved Administration of Kuvan with Food 5114 3